Research News and Research

RSS

Health care experts, lawmakers discuss the overhaul's future

News outlets offer various perspectives on how the health law will hold up in the face of its current and future legislative, economic and judicial challenges.

11 Mar 2011

CBO deficit-reduction options include billions in Medicare, Medicaid cuts

The nonpartisan Congressional Budget Office released a list of deficit-cutting options Thursday that includes hundreds of billions in cuts to Medicare and Medicaid. The two programs account for 38 percent of mandatory spending — more than Social Security — and face a visit to the chopping block as Americans across the political spectrum clamor for the government to keep its spending under control.

11 Mar 2011

Analysis: 1 in 20 American adults is a cancer survivor

A new report from the National Cancer Institute and the Centers for Disease Control and Prevention concluded that nearly 12 million people in the U.S. have survived a bout with this disease.

11 Mar 2011

Abortion wars continue: Funding and insurance coverage issues are among key battlegrounds

News outlets report on the latest developments related to congressional Republican efforts to cut Planned Parenthood funding and state efforts to prohibit health insurance plans sold in their new marketplaces from covering abortion services.

11 Mar 2011

Without fix, docs face 30% Medicare pay cut in 2012

This new figure, updated yesterday by Medicare officials from the previous 28.3 percent "cliff," means the president's plan to keep physician payments flat for the next two years will exceed — by as much as a billion dollars — the funding requested in his 2012 budget proposal.

11 Mar 2011

Ardea Biosciences fourth quarter net loss decreases to $0.6 million

Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and announced fourth quarter and full-year 2010 financial results.

11 Mar 2011

HHS unveils proposed waiver regs for states

The guidance is designed to help implement the health law's waiver provision for state innovation, which would allow some states flexibility as long as they meet key conditions related to coverage, benefits and cost.

11 Mar 2011

ACO regs out soon, says Berwick

ACOs are the subject of great debate, and many in the health policy world are eagerly following Centers for Medicare & Medicaid Services Administrator Don Berwick's every move, waiting for the moment he'll announce the rules defining what an ACO actually is.

11 Mar 2011

ChromaDex pTeroPure Pterostilbene receives 2010 Most Promising Ingredient of the Year award

ChromaDex Corporation, announced today that the Company has been awarded the 2010 North American Health Ingredients Most Promising Ingredient of the Year award by the independent research company, Frost & Sullivan, for its proprietary branded ingredient pTeroPure™ Pterostilbene.

11 Mar 2011

CytRx reports $0.4M net income for 2010 vs. $4.8M net loss for 2009

CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the 12 months ended December 31, 2010, and provided a business update.

11 Mar 2011

BioSpecifics 2010 net loss decreases to $1.5 million

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2010.

11 Mar 2011

Updated NCCN Guidelines for Breast Cancer outline expanded treatment options

Women with metastatic breast cancer have expanded treatment options for treating the disease and in the prevention of skeletal-related events as outlined in the recently updated NCCN Guidelines™ for Breast Cancer. Robert W. Carlson, MD, of Stanford Comprehensive Cancer Center and chair of the NCCN Guidelines Panel for Breast Cancer, presented these and other notable updates to the NCCN Guidelines at the NCCN 16th Annual Conference on March 10, 2011.

11 Mar 2011

Arena fourth quarter net loss decreases to $28.2 million

Arena Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2010, and reviewed recent developments.

11 Mar 2011

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.

11 Mar 2011

Groundbreaking studies presented at Prostate Cancer Research Program's IMPaCT conference

Today, the nation's most prestigious minds in prostate cancer research unveiled the findings of their groundbreaking studies at the Prostate Cancer Research Program's (PCRP's) Innovative Minds in Prostate Cancer Today (IMPaCT) conference in Orlando, Florida.

11 Mar 2011

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010, and provided an update on recent clinical and corporate developments.

11 Mar 2011

Synta fourth-quarter total collaboration revenue decreases to $3.0 million

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported fourth-quarter and full-year 2010 financial results, provided an update on recent progress with its programs, and announced 2011 objectives.

11 Mar 2011

First Edition: March 11, 2011

In today's headlines, news about short- and long-term budget challenges and what could become of funding for health programs.

11 Mar 2011

American Botanical Council honors excellence in herbal medicine

The 6th Annual American Botanical Council Celebration and Awards Ceremony took place last night, honoring individuals and companies who influence the present and future of the herbal medicine movement. The ABC event is part of the annual Natural Products Expo West trade show and Nutracon scientific conference, held in Anaheim, California.

11 Mar 2011

New technique may find 'hidden' receptors in nerve cells

Scientists at The Scripps Research Institute and University of Pennsylvania have found a way to uncover potential drug targets that have so far remained hidden from researchers' view.

11 Mar 2011